Advertisement
Advertisement

NUVL

NUVL logo

Nuvalent, Inc. Class A Common Stock

102.91
USD
Sponsored
+0.17
+0.16%
Apr 13, 13:05 UTC -4
Open

Nuvalent, Inc. Class A Common Stock Profile

About

Nuvalent Inc. is a biopharmaceutical company. It focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. The company's program pipeline includes ROS1-positive and ALK-positive NSCLC. Nuvalent Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

James R. Porter

Headquarters

One Broadway, 14thFloor
Cambridge, MA 02142, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nuvalent.com

Auditor

KPMG LLP

Share holders

7

Employees

228

Nuvalent, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

8.09B

Enterprise Value

7.83B

Enterprise Value/EBITDA(ttm)

-18.40

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-39.29%

Return on Invested Capital(ttm)

-42.96%

Return on Assets(ttm)

-35.01%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-425.41M

Net Income Available to Common(ttm)

-425.38M

Diluted EPS(ttm)

-5.85

Share Statistics

Beta (5Y Monthly)

1.31

52-Week Change

55.23%

S&P 500 52-Week Change

26.62%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

78.62M

Dividend Yield

0.00%

Float4

70.60M

% Held by Insiders

10.20%

% Held by Institutions

97.26%

Balance Sheet

Total Cash(mrq)

1.37B

Total Cash Per Share(mrq)

17.45

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.27%

Quick Ratio(mrq)

15.27%

Book Value Per Share(mrq)

15.96

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.79

Free Cash Flow(ytd)

-275.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement